keyword
https://read.qxmd.com/read/38695547/improvement-of-%C3%AE-cell-function-after-switching-from-dpp-4-inhibitors-to-oral-semaglutide-switch-sema2-post-hoc-analysis
#1
JOURNAL ARTICLE
Hiroshi Nomoto, Sho Furusawa, Hiroki Yokoyama, Yuka Suzuki, Rimi Izumihara, Yuki Oe, Kiyohiko Takahashi, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi, Yoshio Kurihara, Akinobu Nakamura, Tatsuya Atsumi
CONTEXT: Whether continuation of dipeptidyl peptidase-4 inhibitors (DPP-4is) or switching to oral semaglutide is more beneficial for β-cell function is unclear. OBJECTIVE: To assess the efficacy of switching from DPP-4is to oral semaglutide for β-cell function compared with DPP-4i continuation. METHODS: Post hoc analysis of SWITCH-SEMA 2, a multicenter prospective randomized controlled trial on the switch to oral semaglutide vs DPP-4i continuation without dose adjustment for 24 weeks in subjects with type 2 diabetes treated with DPP-4is, was conducted...
May 2, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38693283/silencing-ditylenchus-destructor-cathepsin-l-like-cysteine-protease-has-negative-pleiotropic-effect-on-nematode-ontogenesis
#2
JOURNAL ARTICLE
Guoqiang Huang, Ziwen Cong, Zhonglin Liu, Feng Chen, Alejandra Bravo, Mario Soberón, Jinshui Zheng, Donghai Peng, Ming Sun
Ditylenchus destructor is a migratory plant-parasitic nematode that severely harms many agriculturally important crops. The control of this pest is difficult, thus efficient strategies for its management in agricultural production are urgently required. Cathepsin L-like cysteine protease (CPL) is one important protease that has been shown to participate in various physiological and pathological processes. Here we decided to characterize the CPL gene (Dd-cpl-1) from D. destructor. Analysis of Dd-cpl-1 gene showed that Dd-cpl-1 gene contains a signal peptide, an I29 inhibitor domain with ERFNIN and GNFD motifs, and a peptidase C1 domain with four conserved active residues, showing evolutionary conservation with other nematode CPLs...
May 1, 2024: Scientific Reports
https://read.qxmd.com/read/38691834/hypoglycemic-response-to-dorzagliatin-in-a-patient-with-gck-mody
#3
JOURNAL ARTICLE
Yilin Zhao, Yumin Ma, Tianhao Ba, Xueyao Han, Qian Ren, Linong Ji
OBJECTIVE: Metformin, insulin, and insulin secretagogues do not alter HbA1c levels in glucokinase-maturity-onset diabetes of the young (GCK-MODY). However, the efficacy of the new hypoglycemic drugs on GCK-MODY remains unclear. RESEARCH DESIGN AND METHODS: We describe a case of GCK-MODY with unchanged blood glucose under different therapies during an 8 years' follow-up. His HbA1c and biochemical indices under different hypoglycemic treatments were recorded. RESULTS: Oral antidiabetic drugs, including thiazolidinediones, dipeptidyl peptidase IV inhibitor, α-glucosidase inhibitor, and sodium-glucose cotransporter 2 inhibitor that had not been evaluated previously, did not improve the HbA1c level in this patient...
May 1, 2024: Diabetes Care
https://read.qxmd.com/read/38688196/the-emerging-role-of-deubiquitylating-enzyme-usp21-as-a-potential-therapeutic-target-in-cancer
#4
REVIEW
Zhen-Yuan Shi, Chang-Yun Li, Ru-Yi Chen, Jin-Jin Shi, Yan-Jun Liu, Jian-Fei Lu, Guan-Jun Yang, Jiong Chen
Although certain members of the Ubiquitin-specific peptidases (USPs) have been recognized as promising therapeutic targets for various diseases, research progress regarding USP21 has been relatively sluggish in its early stages. USP21 is a crucial member of the USPs subfamily, involved in diverse cellular processes such as apoptosis, DNA repair, and signal transduction. Research findings from the past decade demonstrate that USP21 mediates the deubiquitination of multiple well-known target proteins associated with critical cellular processes relevant to both disease and homeostasis, particularly in various cancers...
April 25, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38686917/an-in-silico-drug-repurposing-approach-to-identify-hdac1-inhibitors-against-glioblastoma
#5
JOURNAL ARTICLE
Adarsh Gopinathan, Runali Sankhe, Ekta Rathi, Triveni Kodi, Raghavendra Upadhya, K Sreedhara Ranganath Pai, Anoop Kishore
Despite considerable improvement in therapy and diagnosis, brain tumors remain a global public health concern. Among all brain tumors, 80% are due to Glioblastoma. The average survival rate of a patient once diagnosed with glioblastoma is 15 months. Lately, the role of peptidase enzymes, especially Neprilysin, a neutral endopeptidase, is gaining attention for its role in tumor growth regulation. Neprilysin expressions are positively correlated with several tumors including GBM and reduced expression of NEP protein is associated with the pathogenesis of multiple tumors...
April 30, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38683947/glucagon-like-peptide-1-receptor-agonist-use-and-risk-of-thyroid-cancer-scandinavian-cohort-study
#6
JOURNAL ARTICLE
Björn Pasternak, Viktor Wintzell, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Christian Jonasson, Kristian Hveem, Henrik Svanström, Mads Melbye, Peter Ueda
OBJECTIVE: To investigate whether use of glucagon-like peptide 1 (GLP1) receptor agonists is associated with increased risk of thyroid cancer. DESIGN: Scandinavian cohort study. SETTING: Denmark, Norway, and Sweden, 2007-21. PARTICIPANTS: Patients who started GLP1 receptor agonist treatment were compared with patients who started dipeptidyl peptidase 4 (DPP4) inhibitor treatment, and in an additional analysis, patients who started sodium-glucose cotransporter 2 (SGLT2) inhibitor treatment...
April 10, 2024: BMJ: British Medical Journal
https://read.qxmd.com/read/38681395/an-urticarial-and-acral-manifestation-of-bullous-pemphigoid-after-vildagliptin-therapy-a-case-report
#7
Khushboo Bisht, Surajbala Khuraijam, Hannah Theresa Sony, Saurabh Kumbhar
Drug-induced bullous pemphigoid (DBP) may present identical to an idiopathic type of illness. Thus, DBP should be considered as a differential diagnosis when evaluating the cause of bullous pemphigoid (BP) in elderly individuals with diabetes. We present the case of a 65-year-old "young-elderly" female who developed bullous lesions after initiation of medication. This case report casts light on a commonly prescribed antidiabetic drug, a dipeptidyl peptidase-4 inhibitor, vildagliptin, and its unforeseen complication in the elderly...
March 2024: Curēus
https://read.qxmd.com/read/38680706/teneligliptin-mitigates-diabetic-cardiomyopathy-by-inhibiting-activation-of-the-nlrp3-inflammasome
#8
JOURNAL ARTICLE
Gu-Lao Zhang, Yuan Liu, Yan-Feng Liu, Xian-Tao Huang, Yu Tao, Zhen-Huan Chen, Heng-Li Lai
BACKGROUND: Diabetic cardiomyopathy (DCM), which is a complication of diabetes, poses a great threat to public health. Recent studies have confirmed the role of NLRP3 (NOD-like receptor protein 3) activation in DCM development through the inflammatory response. Teneligliptin is an oral hypoglycemic dipeptidyl peptidase-IV inhibitor used to treat diabetes. Teneligliptin has recently been reported to have anti-inflammatory and protective effects on myocardial cells. AIM: To examine the therapeutic effects of teneligliptin on DCM in diabetic mice...
April 15, 2024: World Journal of Diabetes
https://read.qxmd.com/read/38676506/phloridzin-s-diabetic-wound-healing-potential-through-dpp-4-enzyme-inhibition-a-review-article
#9
JOURNAL ARTICLE
Khushi Sharma, Vadivelan Ramachandran, Ashutosh Sharma, Tharani Mohanasundaram, Harshini Mageshkumar
Diabetic wound healing is a dynamic medical process that takes place in an environment within the body that is complex and contains elevated sugar levels, oxygen deprivation, and cellular oxidative stress. Phloridzin (Phlorizin) is one of the most well-known polyphenols found in apples because of its anti-inflammatory, antioxidant, antibacterial, antidiabetic, and antiseptic properties; it can also play a significant part in the healing of diabetic wounds. The study aimed to investigate the role of phloridzin as an efficient DPP-4 inhibitor with additional therapeutic effects in diabetic wound healing, as Dipeptidyl Peptidase-4 (DPP-4) expression increases in response to increases in glucose, Reactive Oxygen Species (ROS), and inflammation...
April 26, 2024: Current Diabetes Reviews
https://read.qxmd.com/read/38675143/characterization-of-plant-derived-natural-inhibitors-of-dipeptidyl-peptidase-4-as-potential-antidiabetic-agents-a-computational-study
#10
JOURNAL ARTICLE
Alomgir Hossain, Md Ekhtiar Rahman, Md Omar Faruqe, Ahmed Saif, Suzzada Suhi, Rashed Zaman, Abdurahman Hajinur Hirad, Mohammad Nurul Matin, Muhammad Fazle Rabbee, Kwang-Hyun Baek
Diabetes, characterized by elevated blood sugar levels, poses significant health and economic risks, correlating with complications like cardiovascular disease, kidney failure, and blindness. Dipeptidyl peptidase-4 (DPP-4), also referred to as T-cell activation antigen CD26 (EC 3.4.14.5.), plays a crucial role in glucose metabolism and immune function. Inhibiting DPP-4 was anticipated as a potential new therapy for diabetes. Therefore, identification of plant-based natural inhibitors of DPP-4 would help in eradicating diabetes worldwide...
April 1, 2024: Pharmaceutics
https://read.qxmd.com/read/38674105/targeting-the-high-density-lipoprotein-proteome-for-the-treatment-of-post-acute-sequelae-of-sars-cov-2
#11
JOURNAL ARTICLE
Karsten Grote, Ann-Christin Schaefer, Muhidien Soufi, Volker Ruppert, Uwe Linne, Aditya Mukund Bhagwat, Witold Szymanski, Johannes Graumann, Yana Gercke, Sümeya Aldudak, Denise Hilfiker-Kleiner, Elisabeth Schieffer, Bernhard Schieffer
Here, we target the high-density lipoprotein (HDL) proteome in a case series of 16 patients with post-COVID-19 symptoms treated with HMG-Co-A reductase inhibitors (statin) plus angiotensin II type 1 receptor blockers (ARBs) for 6 weeks. Patients suffering from persistent symptoms (post-acute sequelae) after serologically confirmed SARS-CoV-2 infection (post-COVID-19 syndrome, PCS, n = 8) or following SARS-CoV-2 vaccination (PVS, n = 8) were included. Asymptomatic subjects with corresponding serological findings served as healthy controls (n = 8/8)...
April 20, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38673881/levels-of-lysozyme-and-slpi-in-bronchoalveolar-lavage-exploring-their-role-in-interstitial-lung-disease
#12
JOURNAL ARTICLE
Rubén Osuna-Gómez, Maria Mulet, Silvia Barril, Elisabet Cantó, Paloma Millan-Billi, Ana Pardessus, David de la Rosa-Carrillo, Diego Castillo, Silvia Vidal
Interstitial lung diseases (ILDs) are characterized by inflammation or fibrosis of the pulmonary parenchyma. Despite the involvement of immune cells and soluble mediators in pulmonary fibrosis, the influence of antimicrobial peptides (AMPs) remains underexplored. These effector molecules display a range of activities, which include immunomodulation and wound repair. Here, we investigate the role of AMPs in the development of fibrosis in ILD. We compare the concentration of different AMPs and different cytokines in 46 fibrotic (F-ILD) and 17 non-fibrotic (NF-ILD) patients by ELISA and using peripheral blood mononuclear cells from in vitro stimulation in the presence of lysozyme or secretory leukocyte protease inhibitor (SLPI) from 10 healthy donors...
April 12, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38672409/dpp-inhibition-enhances-the-efficacy-of-pd-1-blockade-by-remodeling-the-tumor-microenvironment-in-lewis-lung-carcinoma-model
#13
JOURNAL ARTICLE
Mengrong Lei, Junyan Liu, Ying Gao, Wenting Dai, Hanxue Huang, Qingqing Jiang, Zhaoqian Liu
The remarkable efficacy of cancer immunotherapy has been established in several tumor types. Of the various immunotherapies, PD-1/PD-L1 inhibitors are most extensively used in the treatment of many cancers in clinics. These inhibitors restore the suppressed antitumor immune response and inhibit tumor progression by blocking the PD-1/PD-L1 signaling. However, the low response rate is a major limitation in the clinical application of PD-1/PD-L1 inhibitors. Therefore, combination strategies that enhance the response rate are the need of the hour...
March 25, 2024: Biomolecules
https://read.qxmd.com/read/38667773/protein-hydrolysis-as-a-way-to-valorise-squid-processing-byproducts-obtaining-and-identification-of-ace-dpp-iv-and-pep-inhibitory-peptides
#14
JOURNAL ARTICLE
Hajer Bougatef, Assaad Sila, Ali Bougatef, Oscar Martínez-Alvarez
The industrial processing of Argentine shortfin squid to obtain rings generates a significant amount of protein-rich waste, including the skin, which is rich in collagen and attached myofibrillar proteins. This waste is generally discarded. In this study, skin was used as a source of proteins that were hydrolysed using Trypsin, Esperase® or Alcalase®, which released peptides with antioxidant potential and, in particular, antihypertensive (ACE inhibition), hypoglycemic (DPP-IV inhibition) and/or nootropic (PEP inhibition) potential...
March 28, 2024: Marine Drugs
https://read.qxmd.com/read/38667768/glucoregulatory-properties-of-a-protein-hydrolysate-from-atlantic-salmon-salmo-salar-preliminary-characterization-and-evaluation-of-dpp-iv-inhibition-and-direct-glucose-uptake-in-vitro
#15
JOURNAL ARTICLE
Christian Bjerknes, Sileshi Gizachew Wubshet, Sissel Beate Rønning, Nils Kristian Afseth, Crawford Currie, Bomi Framroze, Erland Hermansen
Metabolic disorders are increasingly prevalent conditions that manifest pathophysiologically along a continuum. Among reported metabolic risk factors, elevated fasting serum glucose (FSG) levels have shown the most substantial increase in risk exposure. Ultimately leading to insulin resistance (IR), this condition is associated with notable deteriorations in the prognostic outlook for major diseases, including neurodegenerative diseases, cancer risk, and mortality related to cardiovascular disease. Tackling metabolic dysfunction, with a focus on prevention, is a critically important aspect for human health...
March 28, 2024: Marine Drugs
https://read.qxmd.com/read/38663568/unveiling-the-peptidase-network-orchestrating-hemoglobin-catabolism-in-rhodnius-prolixus
#16
JOURNAL ARTICLE
R Ouali, S Bousbata
Chagas disease is transmitted to humans by obligatory hematophagous insects of Triatominae subfamily, which feeds on various hosts to acquire their nutritional sustenance derived from blood proteins. Hemoglobin digestion is a pivotal metabolic feature of triatomines, representing a key juncture in their competence toward Trypanosoma cruzi; however, it remains poorly understood. To explore the hemoglobin digestion pathway in Rhodnius prolixus, a major Chagas disease vector, we employed an array of approaches for activity profiling of various midgut-associated peptidases using specific substrates and inhibitors...
April 23, 2024: Molecular & Cellular Proteomics: MCP
https://read.qxmd.com/read/38663456/compensational-role-between-cathepsins
#17
REVIEW
Urša Pečar Fonović, Janko Kos, Ana Mitrović
Cathepsins, a family of lysosomal peptidases, play a crucial role in maintaining cellular homeostasis by regulating protein turnover and degradation as well as many specific regulatory actions that are important for proper cell function and human health. Alterations in the activity and expression of cathepsins have been observed in many diseases such as cancer, inflammation, neurodegenerative disorders, bone remodelling-related conditions and others. These changes are not exclusively harmful, but rather appear to be a compensatory response on the lack of one cathepsin in order to maintain tissue integrity...
April 23, 2024: Biochimie
https://read.qxmd.com/read/38660806/immunoproteasomal-inhibition-with-onx-0914-attenuates-atherosclerosis-and-reduces-white-adipose-tissue-mass-and-metabolic-syndrome-in-mice
#18
JOURNAL ARTICLE
Frank H Schaftenaar, Andrea D van Dam, Gerjan de Bruin, Marie A C Depuydt, Jill de Mol, Jacob Amersfoort, Hidde Douna, Menno Meijer, Mara J Kröner, Peter J van Santbrink, Mireia N A Bernabé Kleijn, Gijs H M van Puijvelde, Bogdan I Florea, Bram Slütter, Amanda C Foks, Ilze Bot, Patrick C N Rensen, Johan Kuiper
BACKGROUND: Atherosclerosis is the major underlying pathology of cardiovascular disease and is driven by dyslipidemia and inflammation. Inhibition of the immunoproteasome, a proteasome variant that is predominantly expressed by immune cells and plays an important role in antigen presentation, has been shown to have immunosuppressive effects. METHODS: We assessed the effect of ONX-0914, an inhibitor of the immunoproteasomal catalytic subunits LMP7 (proteasome subunit β5i/large multifunctional peptidase 7) and LMP2 (proteasome subunit β1i/large multifunctional peptidase 2), on atherosclerosis and metabolism in LDLr-/- and APOE*3-Leiden...
April 25, 2024: Arteriosclerosis, Thrombosis, and Vascular Biology
https://read.qxmd.com/read/38658652/preventive-effects-of-sglt2-inhibitors-on-incident-hypertension-in-patients-with-diabetes-who-do-not-have-hypertension
#19
EDITORIAL
Tatsuya Maruhashi, Yukihito Higashi
No abstract text is available yet for this article.
April 24, 2024: Hypertension Research: Official Journal of the Japanese Society of Hypertension
https://read.qxmd.com/read/38658349/real-world-clinical-evidence-of-oral-semaglutide-on-metabolic-abnormalities-in-subjects-with-type-2-diabetes-a-multicenter-retrospective-observational-study-the-sapporo-oral-sema-study
#20
JOURNAL ARTICLE
Sho Furusawa, Hiroshi Nomoto, Chiho Oba-Yamamoto, Jun Takeuchi, Miki Ito, Hiroyoshi Kurihara, Shin Aoki, Aika Miya, Hiraku Kameda, Akinobu Nakamura, Tatsuya Atsumi
Oral semaglutide has potent anti-hyperglycemic efficacy in phase III trials. However, the complicated dosing instructions hamper to use this drug; therefore, we evaluated the efficacy and safety of oral semaglutide in subjects with type 2 diabetes in a real-world clinical setting. In this multi-center retrospective observational study, we analyzed subjects with type 2 diabetes newly treated with an oral semaglutide for >6 months at four medical centers located in Sapporo, Japan. The changes in glycated hemoglobin, body weight, and other metabolic parameters were evaluated and any adverse event leading to semaglutide discontinuation were recorded from February 2021 to December 2022...
April 25, 2024: Endocrine Journal
keyword
keyword
39554
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.